Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
15,000
Total Value
$231,416.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 5,000 | $2.48 | $12,400.00 | 30,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jun 17, 2026 | Sale | 1,268 | $42.83 | $54,304.64 | 28,732 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jun 17, 2026 | Sale | 2,599 | $43.87 | $114,018.39 | 26,133 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jun 17, 2026 | Sale | 1,133 | $44.74 | $50,693.82 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Jun 17, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 121,268 | Direct | โ | View Details |